Evome Medical Technologies Inc (EVMT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 359 | 299 | 167 | 17 | 0 |
| Accounts receivable | -1,000 | -274 | -598 | -194 | 394 |
| Other Working Capital | -724 | 391 | 166 | -39 | 1,216 |
| Other Operating Activity | -1,003 | -839 | -4 | -428 | -2,185 |
| Operating Cash Flow | $-2,368 | $-423 | $-269 | $-643 | $-575 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -21 | N/A | N/A | N/A |
| Net Acquisitions | -246 | -5,274 | 461 | 0 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -192 |
| Sale Of Investment | 0 | 0 | N/A | N/A | 185 |
| Other Investing Activity | -215 | 215 | 477 | 0 | 0 |
| Investing Cash Flow | $-475 | $-5,080 | $938 | $0 | $-7 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 651 | -38 | 1,124 | -187 | N/A |
| Debt Repayment | -290 | -162 | -1,869 | -211 | N/A |
| Other Financing Activity | 4,666 | 0 | 201 | 51 | 5,428 |
| Financing Cash Flow | $5,027 | $-200 | $-545 | $-347 | $5,428 |
| Exchange Rate Effect | -255 | 156 | 291 | -255 | -92 |
| Beginning Cash Position | 6,128 | 11,676 | 11,261 | 12,506 | 7,754 |
| End Cash Position | 8,057 | 6,128 | 11,676 | 11,261 | 12,509 |
| Net Cash Flow | $2,184 | $-5,704 | $123 | $-990 | $4,847 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,368 | -423 | -269 | -643 | -575 |
| Capital Expenditure | -14 | -21 | N/A | N/A | N/A |
| Free Cash Flow | -2,382 | -444 | -269 | -643 | -575 |